Intuitive Surgical

Intuitive Surgical, Inc., headquartered in Sunnyvale, California, is a global leader in robotic-assisted, minimally invasive surgery. Founded in 1995, the company pioneered the da Vinci Surgical System, enabling surgeons to perform complex procedures with enhanced precision, flexibility, and control.

The da Vinci Surgical System comprises a surgeon's console, a patient-side cart with robotic arms, and a high-definition 3D vision system. This setup allows surgeons to operate through small incisions, leading to reduced patient trauma, shorter recovery times, and less postoperative pain.

The system is versatile and applicable across various surgical specialties, including urology, gynecology, thoracic, cardiac, colorectal, pediatric, and general surgery.

Besides the da Vinci system, Intuitive Surgical expanded its product portfolio to include the Ion endoluminal system. This system facilitates minimally invasive biopsies in the lung through diagnostic endoluminal procedures.

Innovation and Support

The company’s commitment to innovation is reflected in the continuous development of advanced technologies and instruments supporting minimally invasive procedures. Its offerings include a comprehensive suite of stapling, energy, and core instruments for the multi-port da Vinci systems.

Intuitive Surgical also provides progressive learning pathways for technology use and robust support infrastructure with services such as installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring.

Global Presence

Intuitive Surgical has a significant global footprint with over 15,000 employees worldwide. It operates offices across multiple regions:

• North America: offices in Peachtree Corners, Georgia, and a manufacturing facility in Mexicali, Mexico, producing over 90% of instruments and accessories for da Vinci Xi and Si systems.
• Europe: offices in Switzerland, Germany, France, and the United Kingdom.
• Asia-Pacific: offices in Japan, South Korea, Singapore, Taiwan, India, Albany, NY, USA, and Sunnyvale, CA, USA.

Achievements and Market Position

Intuitive Surgical's technologies have enabled over 16 million procedures worldwide using da Vinci systems. In Europe alone, more than 410,000 procedures were carried out in 2024.

The company continues to transform surgical practices by offering less invasive options with improved outcomes for patients.

As of August 9, 2025, Intuitive Surgical's stock (ISRG) was trading at $470.08 USD, indicating a strong position in the medical equipment industry.

Company Mission

Intuitive Surgical leads in robotic-assisted surgery, focused on making procedures more effective, less invasive, and easier on surgeons, patients, and families. Through ingenuity and intelligent technology, it expands physicians' potential to heal without constraints.